Cannabis hyperemesis in a dying patient: symptoms may improve with dose reduction rather than complete cessation

A case of cannabis hyperemesis in a patient with advanced ALS highlights that symptoms may be managed by reducing rather than stopping cannabis, that hot bath behavior may be absent in disabled patients, and that primary symptom management must be considered at end of life.

Howard, Ileana·Journal of palliative medicine·2019·Preliminary EvidenceCase Report
RTHC-02076Case ReportPreliminary Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

In a palliative care patient with advanced ALS, cannabis hyperemesis presented atypically without the classic hot bath behavior (due to physical disability). Symptoms may have improved with dose reduction rather than complete abstinence. Primary symptom management (pain, spasticity, nausea, anxiety) must be balanced against CHS risk.

Key Numbers

Patient with advanced ALS. CHS diagnosed. Classic hot bath behavior absent due to disability. Dose reduction (rather than complete cessation) may have been sufficient. Primary symptoms managed with cannabis: pain, spasticity, nausea, anxiety.

How They Did This

Single case report with narrative synthesis of CHS literature, focusing on unique considerations for palliative care patients.

Why This Research Matters

Most CHS guidance assumes patients can simply stop cannabis. In palliative care, where cannabis may be managing critical symptoms like pain and spasticity in terminal illness, the risk-benefit calculation is different, and dose reduction may be a more realistic option.

The Bigger Picture

As more end-of-life patients use cannabis for symptom management, CHS will increasingly occur in populations where cessation is not straightforward. Palliative care needs its own framework for CHS management that prioritizes quality of life.

What This Study Doesn't Tell Us

Single case report. The finding that dose reduction may suffice is based on one patient and cannot be generalized. Atypical presentation makes diagnosis challenging. No comparative data on dose reduction vs cessation strategies.

Questions This Raises

  • ?What is the minimum dose reduction needed to resolve CHS symptoms?
  • ?How common is CHS among palliative care cannabis users?
  • ?Should palliative cannabis prescribing include proactive CHS screening?

Trust & Context

Key Stat:
CHS may respond to dose reduction rather than complete cannabis cessation in palliative patients
Evidence Grade:
Preliminary: single case report with narrative review, though addressing an important clinical gap.
Study Age:
Published in 2019.
Original Title:
Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.
Published In:
Journal of palliative medicine, 22(10), 1227-1231 (2019)
Database ID:
RTHC-02076

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can you treat CHS without stopping cannabis completely?

This case report suggests dose reduction may work in some palliative patients. Standard guidance calls for complete cessation, but for terminally ill patients relying on cannabis for symptom management, the risk-benefit calculation may favor reduction.

Why is CHS different in palliative care?

Disabled patients may not show the classic hot bath behavior. Cannabis may be managing critical symptoms that have no good alternatives. And the usual recommendation of complete cessation may worsen quality of life more than the CHS itself.

Read More on RethinkTHC

Cite This Study

RTHC-02076·https://rethinkthc.com/research/RTHC-02076

APA

Howard, Ileana. (2019). Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.. Journal of palliative medicine, 22(10), 1227-1231. https://doi.org/10.1089/jpm.2018.0531

MLA

Howard, Ileana. "Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.." Journal of palliative medicine, 2019. https://doi.org/10.1089/jpm.2018.0531

RethinkTHC

RethinkTHC Research Database. "Cannabis Hyperemesis Syndrome in Palliative Care: A Case Stu..." RTHC-02076. Retrieved from https://rethinkthc.com/research/howard-2019-cannabis-hyperemesis-syndrome-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.